Department of Trauma Surgery, Liverpool Hospital, Sydney, Australia.
Department of Surgery, Section Trauma Surgery, Amsterdam UMC, Location VUmc, De Boelelaan 1117, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands.
Eur J Trauma Emerg Surg. 2023 Apr;49(2):785-793. doi: 10.1007/s00068-022-02115-6. Epub 2022 Oct 14.
The aim of this study was to describe the utilization of the RAPTOR suite (hybrid theatre) for trauma patients. Ideally, this is used to achieve haemorrhage control in time-critical patients that may require damage control surgery (DCS) and/or interventional radiological (IR) procedures concurrently.
A single-centre, retrospective study identifying all trauma patients that were treated at the level I trauma centre during 2011-2016 was performed. Patients that underwent treatment in the RAPTOR suite were described. Subgroup analyses were performed for trauma patients that underwent interventions within 60 min and patients who underwent a combination of DCS + angioembolization in the RAPTOR suite or in other locations (OR, radiology).
Since its introduction in 2011, 1% of all procedures performed in the RAPTOR suite were trauma related. From 2011 until 2016, 43 trauma patients underwent treatment in the RAPTOR suite. The majority of patients (81%) suffered blunt injury. Most patients were male (70%), with a mean age of 43 years. The mean ISS was 38. In 56% (n = 24) the MTP was activated and in 40% (n = 17) a CT scan was performed prior to treatment. Damage control surgery alone, angioembolization alone and a combination of DCS and angioembolization were performed in 37% (n = 16), 23% (n = 10) and 40% (n = 17) of patients, respectively. Median time to the hybrid suite, procedure time and total time were 56 min (15-704), 160 min (42-404), and 251 min (93-788), respectively.
In the first 5 years following introduction of a hybrid theatre in an urban level I trauma centre, only 1% of patients using the resource has injury-related pathology. Earlier identification of patients requiring this facility may improve timely access and management for this select group of patients needing urgent control of bleeding.
本研究旨在描述 RAPTOR 套件(杂交手术室)在创伤患者中的应用。理想情况下,这是用于及时控制可能需要损伤控制性手术(DCS)和/或介入放射学(IR)程序的时间关键患者的出血。
进行了一项单中心回顾性研究,确定了 2011 年至 2016 年期间在 I 级创伤中心接受治疗的所有创伤患者。描述了在 RAPTOR 套件中接受治疗的患者。对在 60 分钟内接受干预的创伤患者和在 RAPTOR 套件或其他位置(OR,放射科)接受 DCS +血管栓塞联合治疗的患者进行了亚组分析。
自 2011 年推出以来,RAPTOR 套件中进行的 1%的手术与创伤有关。从 2011 年到 2016 年,43 名创伤患者在 RAPTOR 套件中接受了治疗。大多数患者(81%)遭受钝性损伤。大多数患者为男性(70%),平均年龄为 43 岁。ISS 平均为 38。在 56%(n=24)的患者中激活了多器官创伤治疗平台,在 40%(n=17)的患者中在治疗前进行了 CT 扫描。单独进行损伤控制性手术、单独进行血管栓塞和 DCS 联合血管栓塞治疗的患者分别占 37%(n=16)、23%(n=10)和 40%(n=17)。进入杂交手术室、手术时间和总时间的中位数分别为 56 分钟(15-704)、160 分钟(42-404)和 251 分钟(93-788)。
在城市 I 级创伤中心引入杂交手术室的头 5 年中,只有 1%使用该资源的患者有与损伤相关的病理。更早地识别需要这种设施的患者,可能会改善这一特定患者群体对紧急止血控制的及时获得和管理。